Research Agendas and Patenting
In both human genetics and GM crops and foods, questions about the research that is conducted and how it is controlled and shaped are important for society to consider. Supporting research in one area usually means research in another will be limited because funding has to be prioritised. Allowing patents on basic research can restrict who can use the knowledge to develop new treatments or crops. Encouraging research that has commercially benefits will skew research towards areas where discoveries can be patentable, because this is what industry encourages.
GeneWatch believes there should be more public engagement in making decisions about research priorities. We also believe that patents should not be allowed on genes because they are discoveries, not inventions; that by monopolising knowledge at such a basic level research is hampered; and that research is biased towards patentable discoveries rather than being prioritised for health or sustainable food production.
Resources
- Press Releases
- GeneWatch PR: Bioeconomy a science fantasy: new GeneWatch report 25th March 2010
- GeneWatch PR: Brown's Science Speech (27th February 2009) 27th February 2009
- GeneWatch PR: Prime Minister unscientific about science: GeneWatch UK response to PM's speech on science and the economy 3rd November 2006
- GeneWatch PR: New controls needed to maintain independence of science: research shows scientists fail to disclose financial interests in the journal, Nature 2nd November 2006
- Briefings
- GM Debate Briefing - GM Research: Who Decides? 1st June 2003
- Consultation responses
- GeneWatch Submission to House of Lords Science and Technology Committee inquiry on research funding priorities (September 2009) 10th September 2009
- Submission to the DIUS Science and Society consultation 16th October 2008
- GeneWatch UK submission to the Treasury's Cooksey review of health service research 27th July 2006
- Genomics versus public health research - note for Treasury 7th September 2004
- Submission to Government consultation on science and innovation 30th April 2004
- Response to Wanless review of public health 14th November 2003
- Links
- US patent ruling: Myriad BRCA1/2 patents (March 2010)
-
Intellectual Property: The many faces of the public domain.
This book contains a chapter by GeneWatch's Helen Wallace and Sue Mayer.
- Agriculture and Environment Biotechnology Commission (AEBC) - Home Page
